Survivin and apoptosis control

https://doi.org/10.1016/S0065-230X(03)88303-3Get rights and content

Survivin is a member of the inhibitor of apoptosis (IAP) gene family that exhibits differential expression in nearly all human cancers but not in most normal tissues. Recent progress identified a multifunctional survivin pathway positioned at the interface between mitotic progression and apoptosis inhibition, and required to preserve viability of dividing tumor cells (Altieri, 2001; Andersen and Thor, 2002; Jaattela, 1999). The unique properties of survivin have recently found concrete applications for cancer detection, diagnosis, and outcome prediction. In addition, targeting the survivin pathway may offer new therapeutic prospects to lower a general survival threshold in cancer cells. This chapter will focus on the current developments in the field of survivin and its role in apoptosis regulation and mitotic progression. Current perspectives on exploiting the survivin pathway for cancer diagnosis and treatment will be highlighted.

References (161)

  • AdidaC. et al.

    Lancet

    (1998)
  • AdidaC. et al.

    Blood

    (2000)
  • AltieriD.C.

    Trends Mol. Med.

    (2001)
  • AmbrosiniG. et al.

    J. Biol. Chem.

    (1998)
  • AzuhataT. et al.

    J. Pediatr. Surg.

    (2001)
  • BanksD.P. et al.

    Blood

    (2000)
  • BreitschopfK. et al.

    J. Biol. Chem.

    (2000)
  • CarterB.Z. et al.

    Blood

    (2001)
  • ChantalatL. et al.

    Mol. Cell

    (2000)
  • ChenJ. et al.

    Neoplasia

    (2000)
  • ChiodinoC. et al.

    J. Invest. Dermatol.

    (1999)
  • ConwayE.M. et al.

    Blood

    (2000)
  • FukudaS. et al.

    Blood

    (2001)
  • GiananiR. et al.

    Hum. Pathol.

    (2001)
  • GoyalL.

    Cell

    (2001)
  • GrossmanD. et al.

    J. Invest. Dermatol.

    (1999)
  • HanahanD. et al.

    Cell

    (2000)
  • HattoriM. et al.

    Cancer Lett.

    (2001)
  • HuangH. et al.

    J. Biol. Chem.

    (2000)
  • HuangY. et al.

    Cell

    (2001)
  • JaattelaM.

    Exp. Cell. Res.

    (1999)
  • JonesG. et al.

    J. Biol. Chem.

    (2000)
  • LiF. et al.

    J. Biol. Chem.

    (2000)
  • MesriM. et al.

    Am. J. Pathol.

    (2001)
  • MoriN. et al.

    Biochem. Biophys. Res. Commun.

    (2001)
  • MuchmoreS.W. et al.

    Mol. Cell

    (2000)
  • O'ConnorD.S. et al.

    Am. J. Pathol.

    (2000)
  • O'ConnorD.S. et al.

    Cancer Cell

    (2002)
  • PapapetropoulosA. et al.

    J. Biol. Chem.

    (2000)
  • AdamsJ.M. et al.

    Science

    (1998)
  • AdidaC. et al.

    Am. J. Pathol.

    (1998)
  • AdidaC. et al.

    Br. J. Haematol.

    (2000)
  • AmbrosiniG. et al.

    Nat. Med.

    (1997)
  • AndersenM.H. et al.

    Cancer Res.

    (2001)
  • AndersenM.H. et al.

    Histol. Histopathol.

    (2002)
  • AshcroftM. et al.

    Mol. Cell Biol.

    (1999)
  • AshkenaziA. et al.

    Science

    (1998)
  • AshkenaziA. et al.

    J. Clin. Invest.

    (1999)
  • BadieC. et al.

    Mol. Cell Biol.

    (2000)
  • BaoR. et al.

    J. Natl. Cancer Inst.

    (2002)
  • Birkey ReffeyS. et al.

    J. Biol. Chem.

    (2001)
  • BreitschopfK. et al.

    Mol. Cell Biol.

    (2000)
  • ChakravartiA. et al.

    J. Clin. Oncol.

    (2002)
  • DeverauxQ.L. et al.

    Genes Dev.

    (1999)
  • EvanG.L. et al.

    Nature

    (2001)
  • FortugnoP. et al.

    J. Cell Sci.

    (2002)
  • FraserA.G. et al.

    Curr. Biol.

    (1999)
  • GiodiniA. et al.

    Cancer Res.

    (2002)
  • GrayN.S. et al.

    Science

    (1998)
  • GrossmanD. et al.

    J. Clin. Invest.

    (2001)
  • Cited by (144)

    • Survivin promotes a glycolytic switch in CD4<sup>+</sup> T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis

      2022, iScience
      Citation Excerpt :

      Survivin, an oncoprotein encoded by BIRC5, is widely expressed in malignancies and during renewal of nonmalignant hematopoetic cells.18,19 Cytosolic and mitochondrial localization of survivin is tightly linked to its anti-apoptotic function,20 while nuclear localization of survivin has been attributed to its role in the chromosomal passenger complex21 and in the formation of macromolecular complexes, potentially supporting gene expression.18,22,23,24 Shuttling of survivin between cytosol and nucleus is assisted by exportin 1.25,26

    • The role of perilipin 2 in Pseudomonas aeruginosa pulmonary infection

      2020, Respiratory Physiology and Neurobiology
      Citation Excerpt :

      It was consistent with the results that PLIN2 silencing downregulated TOP and TOP2A expression, and reduced cell proliferation. BCL2L1 (Bcl‐xl) (Warren et al., 2019) and BIRC5 (SURVIVIN) (Altieri, 2003) are significant anti-apoptosis proteins. CDK1 is a major component of the cell cycle progression engine, contributing to the mitotic prophase and metaphase (Castedo et al., 2002).

    • Recent development of transition metal complexes with in vivo antitumor activity

      2017, Journal of Inorganic Biochemistry
      Citation Excerpt :

      An accumulation of 5 was observed in mitochondria and the cytoplasm, but not in the nucleus or lysosome. Treatment of 5 also dose-dependently inhibit expression of survivin, an inhibitor of apoptosis [21,22] that is much higher expressed in a majority of human cancer cells [23]. 5 also acted as an activator of caspase-3 and poly (ADP-ribose) polymerase, leading to the induction of apoptosis.

    View all citing articles on Scopus
    View full text